Capricor Therapeutics (CAPR) Stock Price, Quote, News & History | Benzinga

Capricor Therapeutics Inc (CAPR) Stock Price, Quote, News & History

CAPRNASDAQ

Trade with Public

Trade with Public

$27.95

1.907.29%

At close: Jun 17, 5:00 PM EST

$28.66

0.712.56%

After Hours: 6:34 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$27.28

Close

$27.95

Volume / Avg.

1.46M / 1.08M

Day Range

$26.97 - $28.73

52 Wk Range

4.30 - 40.37

Market Cap

$1.66B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

21.11%

Days to Cover

14.28

Recent Capricor Therapeutics Inc News

Capricor Therapeutics Says NS Pharma Delays Could Threaten Access To Duchenne Therapy

Capricor sued Nippon Shinyaku over Deramiocel distribution terms, citing pricing issues and patient access risks.

Vandana Singh

Capricor Therapeutics Stock Slides As Q4 Earnings Miss Estimates

Capricor Therapeutics shares are trading lower Friday afternoon after the biotech company reported a wider-than-expected fourth-quarter loss.

Henry Khederian

Capricor Therapeutics Stock Jumps As FDA Resumes Deramiocel Review

Capricor Therapeutics shares are trading higher Tuesday as the FDA resumed Deramiocel BLA review with a new PDUFA date of August 22, 2026.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-92.63M

Investing Cash Flow (TTM)

-81.05M

Financing Cash Flow (TTM)

250.31M

Free Cash Flow (TTM)

-113.96M

Capital Expenditure (TTM)

-21.33M

Net Change in Cash (TTM)

76.63M

Analyst Trends and Forecast

4

Mar

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.25B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

5.42

Earnings Yield % (TTM)

-8.90%

Earnings Yield % (FWD)

-8.21%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.81

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$105.42M

Debt to Equity

0.05

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$27.28

Close

$27.95

Volume / Avg.

1.46M / 1.08M

Day Range

$26.97 - $28.73

52 Wk Range

4.30 - 40.37

Market Cap

$1.66B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

21.11%

Days to Cover

14.28

About

Sector

Health Care

Industry

Biotechnology

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Capricor Therapeutics (CAPR) stock?

A

You can purchase shares of Capricor Therapeutics (NASDAQ:CAPR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Capricor Therapeutics (CAPR) competitors?

A

There are no as such competitors for Capricor Therapeutics.

Q

What is the forecast, or price target, for Capricor Therapeutics (CAPR) stock?

A

Capricor Therapeutics has a consensus price target of $42.44.

Q

What is the current price for Capricor Therapeutics (CAPR)?

A

The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $28.6648 last updated June 17, 2026 at 6:34 PM EDT.

Q

Does Capricor Therapeutics (CAPR) pay a dividend?

A

There are no upcoming dividends for Capricor Therapeutics.

Q

When is Capricor Therapeutics (NASDAQ:CAPR) reporting earnings?

A

Capricor Therapeutics does not have any upcoming earnings scheduled.

Q

Is Capricor Therapeutics (CAPR) going to split?

A

There is no upcoming split for Capricor Therapeutics.

Q

What sector and industry does Capricor Therapeutics (CAPR) operate in?

A

Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.